Clinical Trial: Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis

Brief Summary: The aim of this study is to conduct survey-based assessments for the safety of air travel in patients with pulmonary Langerhans cell histiocytosis (PLCH). The study will enroll patients through the clinic network at Rare Lung Disease Consortium (RLDC) and through the Histiocytosis Association website. Patients will have access to the questionnaire via REDCap (an online data management system) and each patient will be provided with a link to complete the survey. The investigators plan on enrolling approximately 200 patients with PLCH for the purpose of this study. Secondary aims of this study include further characterization of the clinical aspects of disease and to establish a contact registry for these patients, in order to facilitate future studies.